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Jeffrey You-Ling Shyu, MDa, Judith Burleson, MHSAb, Colleen Tallant, MSb,
David J. Seidenwurm, MDc, Frank J. Rybicki, MD, PhDaPerformance measures in radiology play an increasingly signiﬁcant role in health care quality assessment and
now form the basis for a variety of pay-for-performance programs, including those administered by CMS.
This article introduces the measure development process, beginning with topic selection, followed by measure
development and testing, National Quality Forum endorsement, and implementation. Once implemented,
measures may undergo further testing and be re-endorsed, modiﬁed, or retired. Radiologists should familiarize
themselves with the measures relevant to their practice, develop ways to collect and report data efﬁciently, and
implement the necessary practice changes to meet measure criteria and improve the quality of their practice.
Key Words: Imaging, radiology, quality and safety, performance measure, pay for performance, American
College of Radiology
J Am Coll Radiol 2014;11:456-463. Copyright © 2014 American College of Radiology
under CC BY-NC-ND license.INTRODUCTION
Landmark reports from the Institute of Medicine in the
1990s and 2000s revealed considerable gaps in
the quality and safety of health care in the United States
[1-3]. Since that time, public and private organizations
and governments have increasingly focused on quality
improvement, including the development of perfor-
mance measures in medicine. A performance measure is
a speciﬁc quantiﬁable indicator of an aspect of health
care, expressed as a proportion or percentage of patients
who are treated according to a speciﬁed standard. Per-
formance measures typically focus on structures,
processes, or outcomes of care [4,5]. With appropriate
benchmarks, performance measures allow health care
practitioners to identify areas within their practices that
could be improved [4,5]. For example, the ACR
National Radiology Data Registry provides benchmark
information on numerous measures, allowing radiology
practices to compare their performance measure data
with other practices to determine performance gaps [6].
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efﬁcient care, as well as improved patient outcomes.
Although the primary intent for using performance
measures is to improve health care quality, public and
private payers also increasingly use them as a mecha-
nism to establish a ﬁnancial incentive for practitioners
to improve quality and reduce costs [7]. Performance
measures are now used in a variety of programs that
adjust payments on an individual practitioner, group,
or institutional level. These include several programs
administered by CMS, such as the Physician Quality
Reporting System (PQRS) with the PQRS Mainte-
nance of Certiﬁcation Program Additional Incentive,
the Physician Value-Based Payment Modiﬁer, the
Hospital Outpatient Quality Reporting Program, and
the Inpatient Quality Reporting Program with the
associated Hospital Value-Based Purchasing (Table 1)
[8-14].
The growing emphasis on pay-for-reporting and pay-
for-performance programs, along with the need to iden-
tify radiologist-provided value-added aspects of care and
services, spurred the ACR in 2004 to gather a group of
quality-focused radiologists in Sun Valley, Idaho, to
discuss a road map for improving quality in radiology
[15]. Soon thereafter, CMS began to develop a physician
quality reporting program and encouraged medical spe-
cialty societies to develop quality measures for use in the
program. In 2006, the ACR evaluated the need for
measure development, and the ACR Metrics Committee
was then established to develop radiology performance
measures [16,17]. The Metrics Committee began
collaborating with the AMA’s Physician Consortium for
Performance Improvement (PCPI) for that purpose [18].
This collaboration resulted in several measure sets with
imaging-related measures, many of which are currently
used in the CMS PQRS [19]. In this paper, we focus onª 2014 American College of Radiology
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Table 1. CMS (selected) quality reporting and value-based purchasing programs
Incentive
Program
Level of
Application Incentive/Year Penalty/Year
PQRS Physician/Group 0.50% (2013, 2014) 1.50% (2015)*
2.00% (2016, 2017)†
PQRS+MOC Physician/Group 1.00% (2013, 2014) 1.50% (2015)*
2.00% (2016, 2017)†
VBPM Physician/Group þ TBD based on aggregate
amount of downward payment
for low-scoring groups
(in 2015, groups of 100þ;
in 2016, groups of 10þ)
1.0% (in 2015 for groups of 100+ not participating
in PQRS 2013, or low performing)
2.0% (in 2016 for groups of 10+ not participating
in PQRS or low performing)
HOQR Outpatient Facility N/A 2.00% (FY2013) and beyondz
HIQR Inpatient Facility N/A 2.00% (FY2013) and beyondx
HVBP Inpatient Facility Hospitals may earn an incentive
payment % that is <, ¼, or
> the applicable reduction
% for that program year
(shown as penalties
in next cell)
Reduction in DRG payments, withheld:
2013: 1.0%
2014: 1.25%
2015: 1.5%
2016: 1.75%
2017: 2.0%
Note: DRG ¼ diagnosis-related group; FY ¼ ﬁscal year; HIQR ¼ Hospital Inpatient Quality Reporting; HOQR ¼ Hospital Outpatient Quality Reporting;
HVBP ¼ Hospital Value-Based Purchasing; MOC ¼ Maintenance of Certiﬁcation; NA ¼ not applicable; PQRS ¼ Physician Quality Reporting System;
TBD ¼ to be determined; VBPM ¼ Physician Value-Based Payment Modiﬁer.
*Based on 2013 data.
†Based on 2014 and 2015 data, respectively.
zHospitals must participate in data collection, submission, and public reporting of performance rates to receive the annual payment
update on Hospital Outpatient Prospective Payment System services the following year.
xHospitals must participate in data collection, submission, and public reporting of performance rates in order to receive the annual
payment update on Hospital Inpatient Prospective Payment System services the following year.
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measures frequently used in such programs.OVERVIEW OF MEASURE DEVELOPMENT
Performance measure development and implementation
is a multiple-step process, beginning with identifying a
clinical area that warrants dedicated attention. The
project scope may include general imaging and radiology
considerations and more speciﬁc topics such as radiation
exposure and the appropriateness of certain imaging
studies. Typically, once a focus area is selected, an
environmental scan is conducted to gather relevant
clinical practice guidelines and data to provide evidence
that an improvement in the focus area is needed. After
such a review, a multiple-stakeholder work group is
established, composed of experts in various ﬁelds perti-
nent to the focus area. On the basis of the evidence and
guidelines collected, the workgroup considers potential
measures to draft, begins to develop and reﬁne measure
statements, and identiﬁes numerator and denominator
populations with any appropriate exclusion criteria.
Technical speciﬁcations for reﬁned measures are drafted,
and data sources and data collection feasibility are
assessed, potentially resulting in modiﬁcation of the
draft measure. After speciﬁcation, candidate measures
are tested for feasibility, reliability, validity, and unin-
tended consequences.
Multiple variables carry weight in the ﬁnal approval,
endorsement, use, and sustainability of a measure.
These include organizations involved in the measuredevelopment process (eg, medical specialties, payers, and
consumer representatives), the intended purpose of the
measure (eg, quality improvement, accountability, public
reporting), and deﬁned settings or levels of care (eg,
physician, group, hospital, or system). A developed
measure may proceed to the National Quality Forum
(NQF) for endorsement consideration, or in some cases it
may be implemented before endorsement. Measures may
be used for public pay for reporting or pay for perfor-
mance (such as with the various CMS programs), private
payer pay for performance or quality tiering, hospital
credentialing, or internal quality improvement initiatives.
Since the initial implementation of radiology measures
in PQRS in 2007, requirements for endorsement and
successive maintenance have become increasingly strin-
gent. Measure testing is intended not only to ensure that
measures can improve clinical structures, processes, and
outcomes but also to improve the effectiveness of the
measures. Measures fully endorsed by the NQF must be
maintained over a 3-year cycle, with annual updates
required. At each juncture, performance measures are
reevaluated for continued relevance. A performance
measure may conclusively remain as is, undergo modiﬁ-
cation, be harmonized with related measures, or be
retired. The purpose of this article is to describe a mea-
sure’s “life span,” emphasizing key elements particularly
relevant to measures intended for radiology (Fig. 1).
Part 1: Topic Selection
Currently, nearly 700 measures have been endorsed by
the NQF through the innovation and commitment of
458 Journal of the American College of Radiology/Vol. 11 No. 5 May 201480 measure developers or stewards; these measures are
accessible at the NQF’s website [20]. The opportunity
to expand on the existing measures is not limited to
afﬂuent and inﬂuential organizations. Individuals, hos-
pitals, health insurance providers, specialty societies, and
other consortia are equally empowered to steward the
process.
The measure development process begins with the
selection of an appropriate topic area in need of quality
improvement. A measure development organization,
such as the PCPI, conducts a background review to
compile clinical practice guidelines and relevant research
identifying evidence for measure need in 3 areas: (1)
evidence demonstrating a high-priority aspect of health
care or addressing a speciﬁc national health goal or
priority (eg, the National Quality Strategy priorities;
Table 2) [21]; (2) evidence to support the measure
focus, such as leading to a desired health outcome; and
(3) evidence of a gap or variation in care. Additionally,
an environmental scan is conducted to identify existing
performance measures relevant to the focus area. In one
hypothetical pathway, a performance measure work-
group has identiﬁed a variation in radiology reports.
Speciﬁcally, for carotid imaging studies, including CT
angiographic, MR angiographic, carotid ultrasound, and
neck angiographic studies, these reports do not conﬁrm
that the methods for stenosis measurement are those
validated in randomized controlled outcome trials as
best practice. Failure to provide this information in the
report may cause uncertainty for physicians considering
treatment planning and potentially may lead to adverse
events for patients, including delayed patient care,unnecessarily repeated imaging studies, inappropriate
interventions, or poor outcomes.
Part 2: Measure Development
Although anyone has the power to initiate and develop a
performance measure, those intended for widespread use
are frequently managed by organizations that specialize
in measures development. Historically, one such orga-
nization has been the PCPI, with a focus of physician-
level measurement. Although the PCPI has frequently
overseen measure development, it should be emphasized
that its involvement is not mandatory for measure
endorsement and implementation. The process the
PCPI follows is described below as a generally accepted
approach used for measure development.
The PCPI follows a well-deﬁned, structured process for
measure development [22]. Measure development in the
PCPI is an evidence-based and consensus-based process.
Once the focus for potential clinical improvement is
identiﬁed as described above, an interdisciplinary work
group is convened, often with representatives of multiple
physician specialties, patients, and other health care
consumers; payers such as private health insurance com-
panies; members of other measure development organi-
zations (such as the National Committee for Quality
Assurance); and coding and speciﬁcation experts. The
purpose of this workgroup may be twofold: to build and
test a performance measure and/or to assess existing per-
formance measures for continued suitability in addressing
a deﬁned clinical need.
Upon formation, the work group reviews the state of
the evidence gathered on the focus or topic areasFig 1. Performance measure life span.
Table 2. Agency for Healthcare Research and Quality
National Quality Strategy priorities
 Making care safer by reducing harm caused in the delivery of
care.
 Ensuring that each person and family is engaged as partners
in their care.
 Promoting effective communication and coordination of care.
 Promoting the most effective prevention and treatment
practices for the leading causes of mortality, starting with
cardiovascular disease.
 Working with communities to promote wide use of best
practices to enable healthy living.
 Making quality care more affordable for individuals, families,
employers, and governments by developing and spreading
new health care delivery models.
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cussion centering on an established clinical question, to
determine which practices lead to better or worse care
and to reach consensus on the best measure structure.
Additional literature searches may be performed, and
new studies may be conducted if insufﬁcient evidence
exists to support the basis for the measure. An assessment
of the potential impact of the proposed measure is also
made.
Once the evidence review and impact analysis are
conducted, an eligible population with deﬁned inclusion
and exclusion criteria is identiﬁed for a proposed mea-
sure. The total eligible population is considered the
denominator of a measure. A numerator is also deter-
mined, representing the subset of the denominator that
meets the expected measure criterion. For example, a
measure already exists for the carotid imaging reporting
case previously described, with the denominator repre-
senting all ﬁnalized carotid imaging study reports,
including neck MR angiography, neck CT angiography,
neck duplex ultrasound, and carotid angiography [23].
The measure assesses whether the radiology report makes
“direct or indirect reference to measurements of distal
internal carotid diameter as the denominator for stenosis
measurement.” The numerator in this case is the subset
of ﬁnalized carotid imaging study reports that make
(direct or indirect) reference to measurements of distal
internal carotid diameter as the denominator for stenosis
measurement. For example, to fulﬁll numerator criteria,
measurements of stenosis are required to make reference
to established, validated criteria for measurement, such
as the North American Symptomatic Carotid Endar-
terectomy Trial methodology. Technical speciﬁcations,
including the relevant International Classiﬁcation of
Diseases, ninth rev, Clinical Modiﬁcation, Current
Procedural Terminology (CPT), and CPT category II
codes, and other code sets, are created after the popu-
lation has been deﬁned.
During the PCPI measure development process, after
full work group review and input, measures are posted
online for a 30-day public comment period. During this
window, PCPI members, nonmember health careproviders and consumers, and other health care stake-
holders may submit comments, which may lead to the
revision of a proposed measure. After appropriate revi-
sion, measure speciﬁcations are reﬁned, and the resulting
measure set is put to vote by the PCPI membership. The
membership consists primarily of national medical spe-
cialty societies but also includes several medical specialty
boards, state medical societies, and numerous other
health care professional organizations.
After PCPI approval, the ﬁnalized measure set then
undergoes a testing process, during which it is assessed
for feasibility, reliability, validity, and unintended con-
sequences [24]. Feasibility refers to how easily a practice
can implement a measure, integrate it into the workﬂow,
and collect data for reporting purposes. Reliability refers
to the extent to which different raters can obtain
similar numerators and denominators for a measure and
whether data collection and measure rate calculations
result in the same ﬁndings across different data collec-
tion methods, such as electronic health records, regis-
tries, claims, and paper medical records. Validity refers to
whether a measure truly reﬂects the clinical area it in-
tends to capture. The evidence base may be revisited to
conﬁrm the scientiﬁc merit of a proposed measure, and a
comparison with other measures may be made.
An independently developed measure may receive
PCPI approval. For approval, the independent developer
must be a voting member of the PCPI, the PCPI must
be represented on the measure development panel from
the beginning of the process, and the PCPI methodol-
ogy must be adopted for measure development.
Part 3: NQF Endorsement
After development, a measure steward (such as the PCPI,
a medical institution, or a specialty organization) may
submit the measure to the NQF for endorsement. The
NQF is a not-for-proﬁt, multiple-stakeholder organization
whose mission is to develop and implement a strategy for
health care performance measurement and reporting,
aligned with national goals. The endorsement process
provides an additional level of measure analysis, consensus
development, and feedback. Endorsed measures are
considered “reference standard” measures that are often
widely adopted for pay-for-performance, reporting, or
credentialing purposes. In general, NQF endorsement is
statutorily required for a measure to be implemented by
several CMS programs, with some exceptions.
The NQF’s process for evaluating measures uses 5
standard criteria that are similar to the criteria used by
the PCPI for measure development: (1) impact or pri-
ority, evidence of a quality gap, and evidence to support
its focus; (2) reliability and validity of measure results;
(3) usability; (4) feasibility; and (5) comparison with
similar measures [25].
The NQF has a formalized consensus development
process that can be understood through 8 general steps
[26]. As previously discussed, once an individual or
460 Journal of the American College of Radiology/Vol. 11 No. 5 May 2014organization has decided to proceed through develop-
ment with a novel measure or set of measures, the steward
would ﬁnd an appropriate upcoming NQF “project”
relevant to its measure(s). NQF will convene a steering
committee and sometimes a technical advisory panel for
the project work. Titled a “call for nominations,” this is
the ﬁrst step to organized and efﬁcient measure evalua-
tion. The second step, or “call for candidate standards,” is
an open period for measure stewards to submit candidate
measures or medical best practices using an online form.
Once the call period has ended, the steering committee
(sometimes in the company of the technical advisory
panel) will evaluate the submitted measures by consensus
to determine recommendations for moving the measures
forward for further endorsement review. Measures may
either move forward to the next steps of the consensus
development process or require further development by
the steward before advancing and possible endorsement.
This decision phase, “candidate consensus standard re-
view,” is step 3 of the NQF process.
For measures approved by the committee for pro-
gression toward endorsement, a draft report of the
committee measure recommendations is posted online.
This information is accessible to NQF members and the
public, and comments can be offered by any of these
parties. The committee then reviews these suggestions to
determine if any changes should be made to the rec-
ommendations in the consensus review draft report.
This “public and member comment,” or step 4 of the
NQF consensus development process, precedes step 5,
“member voting” on the candidate measure by all
members of the NQF for endorsement. If the majority
vote approves measure endorsement, step 6 of the NQF
process leaves the fate of the measure to the Consensus
Standards Approval Committee, which meets 3 times
a year to review candidate measures and determine if
appropriate consensus has been reached, according to
the criteria for review with regard to the steering com-
mittee recommendations. The Consensus Standards
Approval Committee takes into account steering com-
mittee draft reports, public comments, and the ﬁnal
voting results before granting full endorsement, granting
time-limited endorsement, or denying the endorsement
of a candidate measure.
Full endorsement for a measure extends 3 years before
a full mandatory review, although annual updates are
performed. In select cases, a measure may receive time-
limited endorsement, with only 1 year of approved
measure use before review, and additional evidence to
support the validity, reliability, usability, or feasibility
of the measure may be required. If the Consensus
Standards Approval Committee has made a positive
recommendation for a measure (full or time-limited
endorsement), it is then sent to the Board of Directors
for ﬁnal approval. Once “board ratiﬁcation,” step 7 of
the process, has been achieved, the measures are pub-
lished online and accessible to the public. Should anyonedispute the ﬁnal decision of the Board of Directors, a 30-
day postendorsement window exists for formal appeal,
the eighth and ﬁnal step of the NQF measure develop-
ment process.
Part 4: Measure Implementation
Once a measure has been developed and/or endorsed, it
may be used by a variety of agencies, hospitals, physician
groups, health insurance companies, and other health
care entities. NQF endorsement may or may not be a
prerequisite to measure implementation. Measures used
for pay-for-performance, pay-for-reporting, accredita-
tion, or maintenance of certiﬁcation purposes often have
NQF endorsement. Measures used for internal quality
improvement may or may not have NQF endorsement.
In many quality reporting programs, data for quality
measures are typically extracted from claims information
or patient medical records. For the PQRS, the Inpatient
Quality Reporting Program and the Hospital Outpatient
Quality Reporting Program online manuals describe how
to implement the available measures, including the rele-
vant patient demographics, International Classiﬁcation
of Diseases, ninth rev, Clinical Modiﬁcation and CPT
codes, and how to calculate the numerator and denom-
inator [23,27-29]. For example, relevant CPT codes for
PQRS measure 195 (NQF 0507), “Stenosis Measure-
ment in Carotid Imaging Reports,” include codes for
neck MR angiography, neck CT angiography, neck
duplex ultrasound, and carotid angiography. A CPT
category II code exists for satisfactory reporting of the
quality measure. Eligible CPT and International Classi-
ﬁcation of Diseases, ninth rev, Clinical Modiﬁcation
codes are explicitly listed for each measure, as are the
inclusion and exclusion criteria.
To tally groups in the numerator and denominator
accurately, cases subject to inclusion and exclusion should
be documented. Criteria for exclusion may include
medical-related, patient-related, or systems-related rea-
sons. Excluded cases should have an appropriate modiﬁer
to the CPT category II codes for the measure.
Part 5: Postimplementation Testing and
Maintenance
Measure data that are gathered after measure develop-
ment or endorsement are applied for the purposes of
quality improvement and accountability. Every 3 years,
an NQF fully endorsed measure undergoes periodic
maintenance review and enhancement, an evaluation
process to ensure that measures remain relevant and
continue to reﬂect best practices. Speciﬁcations (eg,
adding a new imaging modality) may be updated at any
time on the basis of feedback or new evidence. The
measure steward is responsible for submitting updated
information to the NQF. Failure to do so results in a
lapse of NQF endorsement.
Measure maintenance also provides an opportunity
for harmonization with other, similar measures. An ad
hoc review of an endorsed measure may be requested
Table 3. 2013 Physician Quality Reporting System measures most applicable to radiologists
Measure Set Measure
Most Applicable
Subspecialty
Cardiac stress imaging Preoperative Evaluation in Low-Risk Surgery Patients IR, DR
Routine Testing After Percutaneous Coronary Intervention
Testing in Asymptomatic, Low-Risk Patients
Critical care CVC Insertion/Sterile Barrier Technique IR
Nuclear medicine Correlation of Bone Studies NM
Oncology Hormonal Therapy RO
Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patient
Pain Intensity Quantiﬁed
Plan of Care for Pain
Tissue Dose Constraints
Cancer Stage Documented
Osteoporosis Communication Following Fracture DR, IR
Management Following Fracture
Prostate cancer Bone Scan Overuse - Staging RO
Adjuvant Hormonal Therapy
Radiology Fluoroscopy Exposure/Time Recorded DR, IR
Inappropriate Use of BIRADS 3
Stenosis Measurement in Carotid Imaging Studies
Reminder System for Mammograms
Perioperative care Timing of Antibiotics-Ordering Physician IR
Selection of Antibiotic
Discontinuation of Antibiotic
VTE Prophylaxis
Radiation safety Reporting to a Radiation Dose Index Registry DR, IR, NM
Utilization of a Standardized Nomenclature for CT Imaging Description
Appropriateness: Follow-up CT Imaging for Incidental Pulmonary Nodules
According to Recommended Guidelines
Cumulative Count of Potential High Dose Radiation Imaging Studies: CT
Studies and Cardiac Nuclear Medicine Studies
Search for Prior CT Studies through a Secure, Authorized, Media-free,
Shared Archive
CT Images Available for Patient Follow-up and Comparison Purposes
Note: AJCC ¼ American Joint Committee on Cancer; CVC ¼ central venous catheter; DR ¼ diagnostic radiology; IR ¼ interventional radiology;
NM ¼ nuclear medicine; RO ¼ radiation oncology; VTE ¼ venous thromboembolism.
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evaluation process, a measure may be kept, modiﬁed, or
harmonized with other measures, or retired if it is no
longer clinically relevant.
For example, PQRS measure 10, which measured the
documentation rate of the presence or absence of stroke,
hemorrhage, or mass on brain CT and MRI reports, was
retired by the NQF at the end of 2012. Stated reasons for
retirement included a lack of evidence supporting
whether the actual documentation of the presence or
absence of these results affected outcomes or would
change practice, as well as the fact that tissue plasminogen
activator was often administered long before the report
was ﬁnalized. For these and other reasons, the NQF
determined that the measure did not meet the criteria for
importance to measure and report, and the measure is
no longer listed in its endorsed measures set [30].
CONSIDERATIONS FOR RADIOLOGISTS
Although data on the effectiveness of pay-for-performance
initiatives have thus far been varied [31-34], Congress
has mandated the institution of a variety of programs that
will increasingly affect reimbursement for individualpractitioners, groups, and institutions. Limitations of
currently instituted performance measures include wide
variation in background evidence, limitations in the
sources of data collection, and a lack of evidence that
process measures affect outcomes [35]. Moreover, rela-
tively fewmeasures assess important clinical issues such as
the rate of diagnostic errors and the appropriateness of
diagnostic studies and therapies [36,37]. A recent report
by the Robert Wood Johnson Foundation made 7 policy
recommendations for improving the application of per-
formance measurement, including that performance
measures focus on outcomes instead of processes, that
they measure patient experience of care, and that quality
measures be used in conjunction with other quality ini-
tiatives [37].
Nonetheless, performance measures are important
for radiologists because they allow the identiﬁcation of
quality gaps and the assessment of opportunities for
improvement and because reporting is being increasingly
tied to reimbursement. Performance measurement
against deﬁned benchmarks, such as national, regional,
or registry-based benchmarks including the ACR Na-
tional Radiology Data Registry, provides information
462 Journal of the American College of Radiology/Vol. 11 No. 5 May 2014that allows radiology practices to assess their perfor-
mance gaps and plan for quality improvement. Radiol-
ogists should also be involved in developing performance
measures so that new measures are clinically relevant and
best reﬂect what is important for patients, referring
providers, and a radiology practice.
Although any individual or group can draft a per-
formance measure and steward the measure to NQF
endorsement, the ACR Metrics Committee has been
involved in developing most of the radiology-speciﬁc
measures currently in use in the CMS PQRS program.
At present, the active Radiology Measure Set is being
updated with several new draft measures. Many of these
draft measures focus on recommendations related to
incidental ﬁndings and unnecessary follow-up imaging.
Measures may be designed for the goal of NQF
endorsement and use in pay-for-performance programs,
or they may be developed for limited quality improve-
ment programs within a practice. Some radiology-
speciﬁc measures that receive NQF endorsement and
CMS implementation are likely to be outcomes based,
and when applicable, future measures should be rigor-
ously supported by evidence that demonstrates an
improved outcome. In choosing measures for imple-
mentation and reporting, it is important for radiologists
to have measures that are relevant to imaging. There are
nearly 700 NQF-endorsed measures, but only a small
number are relevant to radiologists, and some apply only
to interventional procedures (Table 3). Also, for many
measures that include imaging as an element, the desired
measure result is often attributed to the treating or
referring physician and not the radiologist. Developing
radiology-speciﬁc outcome measures may be a challenge
as the correct performance, interpretation, and reporting
of an imaging study may only contribute indirectly to a
good patient outcome. A key goal of the ACR Metrics
Committee within the Commission of Quality and
Safety is to develop measures attributable to radiologists.
Although this is an ongoing process, radiologists should
familiarize themselves with the complex family of public
and private programs now using measures to modify
reimbursement. It is also incumbent on radiology
practices to develop plans for data gathering so that
quality gaps can be identiﬁed and data easily reported for
reimbursement purposes.
CONCLUSIONS
Performance measures are now an established compo-
nent of quality assessment and reimbursement in health
care and will only grow in importance. Measures
development ﬁrst entails identifying a clinical area in
need of improvement and is a multiple-step process that
requires evidence gathering, specifying inclusion and
exclusion criteria, and testing. A developed measure may
be further submitted to the NQF for endorsement;
endorsed measures are then typically used in value-based
purchasing programs. Implemented measures routinelyundergo maintenance and may be revised, harmonized
with other measures, or retired depending on evolving
best practices. Radiologists should be involved in mea-
sure development to ensure that they are clinically
important and relevant to a radiology practice.
TAKE-HOME POINTS
 Performance measures are now an established com-
ponent of quality assessment and reimbursement in
health care and will continue to grow in importance
and use.
 Measure development is a multiple-step process
that begins with identifying a clinical area in need
of improvement, followed by gathering evidence. It
continues with appropriate speciﬁcation, then testing
of validity and usability. A developed measure may be
further submitted for NQF endorsement.
 Once developed or endorsed, measures may be
implemented by value-based purchasing programs to
determine reimbursement.
 Radiologists should be involved in measure develop-
ment to ensure that new measures are clinically
important to a radiology practice.
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